These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1414152)

  • 1. Role of the antiglucocorticoid RU 486 in the prevention of steroid-induced hypertension.
    Opoku J; Kalimi M
    Acta Endocrinol (Copenh); 1992 Sep; 127(3):258-61. PubMed ID: 1414152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
    Minato M; Honda M; Hatano M
    Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):29-41. PubMed ID: 2307256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat.
    Iaina A; Shochat J; Serban I; Kapuler S; Gavendo S; Goldfarb D; Eliahou HE
    J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of chicken extract against deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Okui T; Ono H; Kiso Y; Tanaka T
    Biol Pharm Bull; 2001 Oct; 24(10):1181-4. PubMed ID: 11642328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats.
    Balasubramaniam G; Lee HS; Mah SC
    Eur J Pharmacol; 1995 Mar; 276(1-2):183-90. PubMed ID: 7781688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
    Van den Berg DT; de Kloet ER; de Jong W
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E927-33. PubMed ID: 7810636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hypertension in animals with reduced total peripheral resistance.
    Huang M; Hester RL; Coleman TG; Smith MJ; Guyton AC
    Hypertension; 1992 Dec; 20(6):828-33. PubMed ID: 1452299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central vasopressin is required for the complete development of deoxycorticosterone-salt hypertension in rats with hereditary diabetes insipidus.
    Liang J; Toba K; Ouchi Y; Nagano K; Akishita M; Kozaki K; Ishikawa M; Eto M; Orimo H
    J Auton Nerv Syst; 1997 Jan; 62(1-2):33-9. PubMed ID: 9021647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Ammarguellat F; Larouche I; Schiffrin EL
    Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac output and the blood pressure increase in deoxycorticosterone acetate-salt hypertension after nicotine infusion.
    Passmore JC; Jimenez AE; Pierce WM
    Clin Exp Hypertens A; 1991; 13(1):83-102. PubMed ID: 2022074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
    Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
    Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.
    Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D
    Endocrinology; 1979 Sep; 105(3):600-4. PubMed ID: 157270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats.
    Elhaïmeur F; Courderot-Masuyer C; Nicod L; Bobillier-Chaumont S; Robin S; Richert L; Berthelot A
    Can J Physiol Pharmacol; 2003 May; 81(5):469-75. PubMed ID: 12774853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.